Despite randomised clinical trials (RCTs) being the gold standard for drug approval studies, the shift towards precision medicine has increased the use of single-arm trials (SATs). SATs lack results ...
"Smartphones do their best to block scam links, so attackers use tricks to make their links clickable," said Joshua McKenty, CEO of Polyguard.ai, a cybersecurity company that helps businesses protect ...
Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback